![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Publisher's version)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
| Item Type: | Review |
|---|---|
| Title: | Gut-immune axis and cardiovascular risk in chronic kidney disease |
| Creators Name: | Behrens, F., Bartolomaeus, H., Wilck, N. and Holle, J. |
| Abstract: | Patients with chronic kidney disease (CKD) suffer from marked cardiovascular morbidity and mortality, so lowering the cardiovascular risk is paramount to improve quality of life and survival in CKD. Manifold mechanisms are hold accountable for the development of cardiovascular disease (CVD), and recently inflammation arose as novel risk factor significantly contributing to progression of CVD. While the gut microbiome was identified as key regulator of immunity and inflammation in several disease, CKD-related microbiome-immune interaction gains increasing importance. Here, we summarize the latest knowledge on microbiome dysbiosis in CKD, subsequent changes in bacterial and host metabolism and how this drives inflammation and CVD in CKD. Moreover, we outline potential therapeutic targets along the gut-immune-cardiovascular axis that could aid combat CVD development and high mortality in CKD. |
| Keywords: | Cardiovascular Disease, Chronic Kidney Disease, Immunity, Inflammation, Microbiome, Animals, Mice |
| Source: | Clinical Kidney Journal |
| ISSN: | 2048-8505 |
| Publisher: | Oxford University Press |
| Volume: | 17 |
| Number: | 1 |
| Page Range: | sfad303 |
| Date: | January 2024 |
| Official Publication: | https://doi.org/10.1093/ckj/sfad303 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
